Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study

scientific article published on 21 September 2019

Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10552-019-01233-8
P698PubMed publication ID31542834

P50authorJoAnn E. MansonQ6204013
Garnet L AndersonQ37387870
Louise A. BrintonQ58623846
Thomas RohanQ87760016
Lewis KullerQ88077314
Roni T FalkQ89510546
Britton TrabertQ89761192
Ruth PfeifferQ90909936
Marcia L. StefanickQ109542605
Margery L GassQ114309265
P2093author name stringXia Xu
Lihong Qi
Nicolas Wentzensen
Sally B Coburn
P2860cites workAssociation between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studiesQ24619808
Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective studyQ28361980
Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogensQ28369979
Risk factors for epithelial ovarian cancer by histologic subtypeQ33552610
The women's health initiative observational study: baseline characteristics of participants and reliability of baseline measuresQ34272017
Early pregnancy sex steroids and maternal risk of epithelial ovarian cancerQ34807665
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studiesQ35594488
Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?Q36189328
Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health studyQ36288027
Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health StudyQ36421847
Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).Q36676316
Circulating Estrogens and Postmenopausal Ovarian Cancer Risk in the Women's Health Initiative Observational StudyQ36918178
Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal WomenQ37059802
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort ConsortiumQ37234793
Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004.Q37442687
Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriersQ37638732
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancerQ37657957
Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohortQ38345889
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study GroupQ39513392
Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B ∼ FIT CohortQ41002144
Circulating levels of sex steroid hormones and risk of ovarian cancerQ43485500
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal womenQ44675827
Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health studyQ47293593
Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry.Q53329150
Serum gonadotropins and steroid hormones and the development of ovarian cancerQ70918427
Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?Q91294555
P433issue11
P921main subjectestrogenQ277954
endometrial cancerQ944777
P304page(s)1201-1211
P577publication date2019-09-21
P1433published inCancer Causes & ControlQ325957
P1476titleCirculating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women's Health Initiative Observational Study
P478volume30

Reverse relations

Q122920530An Assessment of Serum Selenium Concentration in Women with Ovarian Cancercites workP2860

Search more.